Transcription of Public Assessment Report Mutual Recognition Procedure
{{id}} {{{paragraph}}}
Example: bachelor of science
Public Assessment Report Mutual Recognition Procedure
Public Assessment Report Mutual Recognition Procedure SAYANA PRESS 104 ml suspension for injection PL 00057/1093; UK/H/0960/002/DC Medroxyprogesterone acetate Pfizer LimitedPAR SAYANA PRESS 104 ml suspension for injection UK/H/0960/002/DC 2 LAY SUMMARY This is a summary of the Public Assessment Report (PAR) for SAYANA PRESS 104 suspension for injection (PL 00057/1093; UK/H/0960/002/DC). It explains how SAYANA PRESS 104 suspension for injection was assessed and its authorisation recommended, as well as its conditions of use. It is not intended to provide practical advice on how to use this product. For ease of reading, throughout this PAR, the product SAYANA PRESS 104 suspension for injection will be called SAYANA PRESS. For practical information about using SAYANA PRESS, patients should read the Package Leaflet or contact their doctor or pharmacist. What is SAYANA PRESS and what is it used for? SAYANA PRESS is a line-extension of the existing product licence for SAYANA 104 suspension for injection in prefilled syringe (PFS) (PL 00057/0589), using the Uniject delivery system.
PAR SAYANA PRESS 104 mg/0.65 ml suspensi on for injection UK/H/0960/002/DC 2 LAY SUMMARY This is a summary of the Public Assessment Report (PAR) for SAYANA PRESS
Loading..
Tags:
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Related search queries
Public Assessment Report Repeat-Use Mutual Recognition, Public Assessment Report . Repeat-Use Mutual Recognition Procedure, Procedure, All About Regulatory Affairs, Assessment report, Mutual recognition, Performance Assessment, Public, Performance, The Mutual Recognition and Decentralised Procedures, RECOMMENDATIONS ON MULTIPLE/DUPLICATE, RECOMMENDATIONS ON MULTIPLE/DUPLICATE APPLICATIONS, MUTUAL RECOGNITION AND DECENTRALISED PROCEDURES, WHO Drug Information